Insulet Corp (PODD)
182.27
+5.87
(+3.33%)
USD |
NASDAQ |
May 07, 13:27
Insulet Price to Book Value: 17.40 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 06, 2024 | 16.83 |
May 03, 2024 | 16.65 |
May 02, 2024 | 16.55 |
May 01, 2024 | 16.25 |
April 30, 2024 | 16.41 |
April 29, 2024 | 16.25 |
April 26, 2024 | 15.86 |
April 25, 2024 | 15.67 |
April 24, 2024 | 15.96 |
April 23, 2024 | 15.96 |
April 22, 2024 | 15.69 |
April 19, 2024 | 15.87 |
April 18, 2024 | 15.72 |
April 17, 2024 | 15.87 |
April 16, 2024 | 16.48 |
April 15, 2024 | 16.60 |
April 12, 2024 | 16.72 |
April 11, 2024 | 17.14 |
April 10, 2024 | 16.93 |
April 09, 2024 | 16.99 |
April 08, 2024 | 16.23 |
April 05, 2024 | 15.75 |
April 04, 2024 | 15.58 |
April 03, 2024 | 15.73 |
April 02, 2024 | 15.66 |
Date | Value |
---|---|
April 01, 2024 | 16.04 |
March 28, 2024 | 16.36 |
March 27, 2024 | 16.15 |
March 26, 2024 | 15.80 |
March 25, 2024 | 15.72 |
March 22, 2024 | 15.68 |
March 21, 2024 | 15.90 |
March 20, 2024 | 15.96 |
March 19, 2024 | 16.28 |
March 18, 2024 | 16.38 |
March 15, 2024 | 15.83 |
March 14, 2024 | 16.00 |
March 13, 2024 | 16.75 |
March 12, 2024 | 17.35 |
March 11, 2024 | 17.29 |
March 08, 2024 | 17.14 |
March 07, 2024 | 16.75 |
March 06, 2024 | 15.81 |
March 05, 2024 | 15.64 |
March 04, 2024 | 16.02 |
March 01, 2024 | 16.15 |
February 29, 2024 | 15.65 |
February 28, 2024 | 15.61 |
February 27, 2024 | 15.90 |
February 26, 2024 | 16.11 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
14.69
Minimum
Oct 12 2023
240.29
Maximum
May 11 2020
49.10
Average
35.64
Median
Price to Book Value Benchmarks
Abbott Laboratories | 4.759 |
Stryker Corp | 6.582 |
Tandem Diabetes Care Inc | 11.80 |
Becton Dickinson & Co | 2.689 |
ResMed Inc | 6.873 |
Price to Book Value Related Metrics
PE Ratio | 62.64 |
PS Ratio | 8.003 |
PEG Ratio | 0.0132 |
Price to Free Cash Flow | 372.11 |
Price | 182.27 |
Earnings Yield | 1.60% |
Market Cap | 12.75B |
PEGY Ratio | 0.0132 |
Operating PE Ratio | 61.74 |
Normalized PE Ratio | 62.64 |